Synergism between the metabolic syndrome components and cancer incidence: results from a prospective nested case–control study based on the China Health and Retirement Longitudinal Study (CHARLS)

Lin Li,Lingkai Xu,Dongkui Xu,Fang Meng,Xiaochen Shu,Junlan Qiu

doi:10.1136/bmjopen-2022-061362

Synergism between the metabolic syndrome components and cancer incidence: results from a prospective nested case–control study based on the China Health and Retirement Longitudinal Study (CHARLS)

Lin Li, Lingkai Xu + Show 4 more

Open Access

https://doi.org/10.1136/bmjopen-2022-061362

Copy DOI

Journal: BMJ Open	Publication Date: Sep 1, 2022
Citations: 5	License type: open-access

Affiliation: Soochow University, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou Institute of Systems Medicine, Suzhou University of Science and Technology, Nanjing Medical University

#Metabolic Syndrome Components #Unique Component + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectivesSynergism between the metabolic syndrome (MetSyn) components and cancer incidence still remains inconclusive. We aimed to investigate the unique or joint role of MetSyn components in cancer onset.DesignWe conducted a...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: BMJ Open

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.